Tweet
The flu vaccine is 'a little less effective' this year while the influenza epidemic in metropolitan France more strongly affects the elderly, is a specialist in confirming the Parisian information.
Health authorities are facing a particular concern this winter with the flu vaccine. ' Viral 'strain' it contains is about - but about only - the virus circulating at this time. The vaccine is less effective this year than in previous years, even if it is not ', writes the newspaper.
A situation referred to in an e-mail from February 23 of the regional agency of Ile-de-France (ARS - IDF) health managers to accommodation of elderly dependent (Ehpad) which Le Parisien produced a facsimile. It speaks of risk resulting from this 'majority strain AH3N2 affecting particularly the elderly, with a risk of increased mortality', notes the daily. Another concern, 'Vaccine protection against this strain is not absolute'.
The vaccine, numerous months of which beforehand by the worldwide Organization of health (WHO) decide on composition, includes a protection against a virus H3N2, the main virus in circulation nowadays. But nowadays ' there are some variable of the virus H3N2, different from the vaccinal stump ', says the professor Bruno Lina, manager of the laboratory of virology and human pathologies (VirPath) in Lyons. ' Because of this or that the vaccinal stump is a little less competitive, but it does not mean that vaccine is useless, he adds. This winter, we came back in a classical infectious situation which clamps down hard among the old persons. '
Health authorities are facing a particular concern this winter with the flu vaccine. ' Viral 'strain' it contains is about - but about only - the virus circulating at this time. The vaccine is less effective this year than in previous years, even if it is not ', writes the newspaper.
A situation referred to in an e-mail from February 23 of the regional agency of Ile-de-France (ARS - IDF) health managers to accommodation of elderly dependent (Ehpad) which Le Parisien produced a facsimile. It speaks of risk resulting from this 'majority strain AH3N2 affecting particularly the elderly, with a risk of increased mortality', notes the daily. Another concern, 'Vaccine protection against this strain is not absolute'.
The vaccine, numerous months of which beforehand by the worldwide Organization of health (WHO) decide on composition, includes a protection against a virus H3N2, the main virus in circulation nowadays. But nowadays ' there are some variable of the virus H3N2, different from the vaccinal stump ', says the professor Bruno Lina, manager of the laboratory of virology and human pathologies (VirPath) in Lyons. ' Because of this or that the vaccinal stump is a little less competitive, but it does not mean that vaccine is useless, he adds. This winter, we came back in a classical infectious situation which clamps down hard among the old persons. '
